• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2016年回顾:类风湿关节炎治疗的新进展

One year in review 2016: novelties in the treatment of rheumatoid arthritis.

作者信息

Calabrò Andrea, Caterino Anna Laura, Elefante Elena, Valentini Valentina, Vitale Antonio, Talarico Rosaria, Cantarini Luca, Frediani Bruno

机构信息

Rheumatology Unit, Department of Experimental and Clinical Medicine, Azienda Ospedaliero-Universitaria Careggi, University of Florence, Italy.

Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Italy.

出版信息

Clin Exp Rheumatol. 2016 May-Jun;34(3):357-72. Epub 2016 May 30.

PMID:27268779
Abstract

Rheumatoid arthritis (RA) is a chronic disease characterised by inflammation of the synovial tissue in joints, which can lead to joint destruction. The primary goal of the treatment is to control pain and inflammation, reduce joint damage and disability, and maintain or improve physical function and quality of life. The present review is aimed at providing a critical analysis of the recent literature on the novelties in the treatment of RA, with a particular focus on the most relevant studies published over the last year.

摘要

类风湿性关节炎(RA)是一种以关节滑膜组织炎症为特征的慢性疾病,可导致关节破坏。治疗的主要目标是控制疼痛和炎症,减少关节损伤和残疾,并维持或改善身体功能和生活质量。本综述旨在对近期关于类风湿性关节炎治疗新进展的文献进行批判性分析,特别关注过去一年发表的最相关研究。

相似文献

1
One year in review 2016: novelties in the treatment of rheumatoid arthritis.2016年回顾:类风湿关节炎治疗的新进展
Clin Exp Rheumatol. 2016 May-Jun;34(3):357-72. Epub 2016 May 30.
2
One year in review 2017: novelties in the treatment of rheumatoid arthritis.2017年回顾:类风湿关节炎治疗的新进展
Clin Exp Rheumatol. 2017 Sep-Oct;35(5):721-734. Epub 2017 Sep 13.
3
One year in review: novelties in the treatment of rheumatoid arthritis.年度回顾:类风湿关节炎治疗的新进展
Clin Exp Rheumatol. 2015 Jan-Feb;33(1):102-8. Epub 2015 Feb 26.
4
[How I treat...rheumatoid arthritis. The arrival of a new therapeutic era: anti-tumor necrosis factor alpha antibodies].
Rev Med Liege. 2002 Aug;57(8):486-92.
5
The therapeutic potential of TNF-alpha blockade in rheumatoid arthritis.肿瘤坏死因子-α 阻断剂在类风湿关节炎中的治疗潜力。
Expert Opin Investig Drugs. 2003 Jul;12(7):1087-95. doi: 10.1517/13543784.12.7.1087.
6
Clinical trial outcome of anti-tumour necrosis factor alpha therapy in rheumatic arthritis.抗肿瘤坏死因子α疗法在类风湿性关节炎中的临床试验结果
Cytokine. 2004;28(4-5):158-61. doi: 10.1016/j.cyto.2004.07.009.
7
TNF alpha as a therapeutic target in rheumatoid arthritis.肿瘤坏死因子α作为类风湿关节炎的治疗靶点。
Circ Shock. 1994 Aug;43(4):179-84.
8
How antirheumatic drugs protect joints from damage in rheumatoid arthritis.抗风湿药物如何在类风湿关节炎中保护关节免受损伤。
Arthritis Rheum. 2008 Oct;58(10):2936-48. doi: 10.1002/art.23951.
9
[New therapeutic strategy of rheumatoid arthritis to reach the goal of suppression of joint destruction].类风湿关节炎实现抑制关节破坏目标的新治疗策略
Clin Calcium. 2007 Apr;17(4):463-73.
10
[Rheumatoid arthritis: current status of therapy].[类风湿关节炎:治疗现状]
Tunis Med. 2007 Jan;85(1):1-8.

引用本文的文献

1
Effective Assessment of Rheumatoid Arthritis Disease Activity and Outcomes Using Monocyte Chemotactic Protein-1 (MCP-1) and Disease Activity Score 28-MCP-1.基于趋化因子(MCP-1)和 28 关节疾病活动度评分(DAS28)的单核细胞化学引诱蛋白-1 对类风湿关节炎疾病活动度和结局的有效评估。
Int J Mol Sci. 2024 Oct 23;25(21):11374. doi: 10.3390/ijms252111374.
2
Longitudinal F-VUIIS1008 PET imaging in a rat model of rheumatoid arthritis.类风湿性关节炎大鼠模型中的纵向F-VUIIS1008正电子发射断层显像
Front Chem. 2022 Dec 23;10:1064518. doi: 10.3389/fchem.2022.1064518. eCollection 2022.
3
Association of Rheumatoid Arthritis with Diabetic Comorbidity: Correlating Accelerated Insulin Resistance to Inflammatory Responses in Patients.
类风湿关节炎与糖尿病合并症的关联:探究患者中加速的胰岛素抵抗与炎症反应的相关性
J Multidiscip Healthc. 2021 Apr 12;14:809-820. doi: 10.2147/JMDH.S285469. eCollection 2021.
4
The inhibition of Src kinase suppresses the production of matrix metalloproteinases in from synovial fibroblasts and inhibits MAPK and STATs pathways.Src 激酶的抑制可抑制滑膜成纤维细胞中基质金属蛋白酶的产生,并抑制 MAPK 和 STATs 通路。
Turk J Med Sci. 2021 Aug 30;51(4):2142-2149. doi: 10.3906/sag-2008-274.
5
Improvement of Certolizumab Fab' properties by PASylation technology.通过聚唾液酸化技术改善赛妥珠单抗Fab'的特性。
Sci Rep. 2020 Oct 28;10(1):18464. doi: 10.1038/s41598-020-74549-0.
6
Neuraxial Cytokines in Pain States.在疼痛状态下的神经轴细胞因子。
Front Immunol. 2020 Jan 28;10:3061. doi: 10.3389/fimmu.2019.03061. eCollection 2019.
7
Peficitinib Inhibits the Chemotactic Activity of Monocytes via Proinflammatory Cytokine Production in Rheumatoid Arthritis Fibroblast-Like Synoviocytes.培非替尼通过类风湿关节炎成纤维样滑膜细胞中促炎细胞因子的产生抑制单核细胞的趋化活性。
Cells. 2019 Jun 9;8(6):561. doi: 10.3390/cells8060561.
8
Downregulated MEG3 participates in rheumatoid arthritis via promoting proliferation of fibroblast-like synoviocytes.下调的MEG3通过促进成纤维样滑膜细胞增殖参与类风湿性关节炎。
Exp Ther Med. 2019 Mar;17(3):1637-1642. doi: 10.3892/etm.2018.7100. Epub 2018 Dec 14.
9
The analgesic effect and possible mechanisms by which koumine alters type II collagen-induced arthritis in rats.苦参碱对大鼠Ⅱ型胶原诱导关节炎的镇痛作用及可能机制。
J Nat Med. 2019 Jan;73(1):217-225. doi: 10.1007/s11418-018-1229-3. Epub 2018 Jul 27.
10
The Binomial Parasite-Host Immunity in the Healing Process and in Reactivation of Human Tegumentary Leishmaniasis.人类皮肤利什曼病愈合过程及复发中寄生虫与宿主的二项式免疫。
Front Microbiol. 2018 Jun 19;9:1308. doi: 10.3389/fmicb.2018.01308. eCollection 2018.